Document Type
Article
Publication Date
2022
DOI
10.3390/tropicalmed7080155
Publication Title
Tropical Medicine and Infectious Disease
Volume
7
Issue
8
Pages
155 (1-9)
Abstract
The effectiveness of artemisinin-based combination therapies (ACTs) depends not only on that of artemisinin but also on that of partner molecules. This study aims to evaluate the prevalence of mutations in the Pfdhfr, Pfdhps, and Pfmdr1 genes from isolates collected during a clinical study. Plasmodium genomic DNA samples extracted from symptomatic malaria patients from Dogondoutchi, Niger, were sequenced by the Sanger method to determine mutations in the Pfdhfr (codons 51, 59, 108, and 164), Pfdhps (codons 436, 437, 540, 581, and 613), and Pfmdr1 (codons 86, 184, 1034, and 1246) genes. One hundred fifty-five (155) pre-treatment samples were sequenced for the Pfdhfr, Pfdhps, and Pfmdr1 genes. A high prevalence of mutations in the Pfdhfr gene was observed at the level of the N51I (84.97%), C59R (92.62%), and S108N (97.39%) codons. The key K540E mutation in the Pfdhps gene was not observed. Only one isolate was found to harbor a mutation at codon I431V. The most common mutation on the Pfmdr1 gene was Y184F in 71.43% of the mutations found, followed by N86Y in 10.20%. The triple-mutant haplotype N51I/C59R/S108N (IRN) was detected in 97% of the samples. Single-mutant (ICS and NCN) and double-mutant (IRS, NRN, and ICN) haplotypes were prevalent at 97% and 95%, respectively. Double-mutant haplotypes of the Pfdhps (581 and 613) and Pfmdr (86 and 184) were found in 3% and 25.45% of the isolates studied, respectively. The study focused on the molecular analysis of the sequencing of the Pfdhfr, Pfdhps, and Pfmdr1 genes. Although a high prevalence of mutations in the Pfdhfr gene have been observed, there is a lack of sulfadoxine pyrimethamine resistance. There is a high prevalence of mutation in the Pfmdr184 codon associated with resistance to amodiaquine. These data will be used by Niger’s National Malaria Control Program to better monitor the resistance of Plasmodium to partner molecules in artemisinin-based combination therapies.
Rights
© 2022 by the authors.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
Data Availability
Article states: "The data is accessible on request at the Center for Medical and Sanitary Research in Niamey. BP: 11887."
Original Publication Citation
Issa, I., Lamine, M. M., Hubert, V., Ilagouma, A., Adehossi, E., Mahamadou, A., Lobo, N. F., Sarr, D., Shollenberger, L. M., Sandrine, H., Jambou, R., & Laminou, I. M. (2022). Prevalence of mutations in the Pfdhfr, Pfdhps, and Pfmdr1 genes of malarial parasites isolated from symptomatic patients in Dogondoutchi, Niger. Tropical Medicine and Infectious Disease, 7(8), 1-9, Article 155. https://doi.org/10.3390/tropicalmed7080155
Repository Citation
Issa, Ibrahima; Lamine, Mahaman Moustapha; Hubert, Veronique; Ilagouma, Amadou; Adehossi, Eric; Mahamadou, Aboubacar; Lobo, Neil F.; Sarr, Demba; Shollenberger, Lisa M.; Sandrine, Houze; Jambou, Ronan; and Laminou, Ibrahim Maman, "Prevalence of Mutations in the Pfdhfr, Pfdhps, and Pfmdr1 Genes of Malarial Parasites Isolated from Symptomatic Patients in Dogondoutchi, Niger" (2022). Biological Sciences Faculty Publications. 489.
https://digitalcommons.odu.edu/biology_fac_pubs/489
ORCID
0000-0002-0943-0838 (Shollenberger)